| human | Q5 |
| P166 | award received | Fellow of the American Association for the Advancement of Science | Q5442484 |
| P69 | educated at | Case Western Reserve University | Q1047060 |
| P108 | employer | Boston University | Q49110 |
| The Forsyth Institute | Q7734873 | ||
| P734 | family name | Van Dyke | Q29380713 |
| Van Dyke | Q29380713 | ||
| Van Dyke | Q29380713 | ||
| P735 | given name | Thomas | Q16428906 |
| Thomas | Q16428906 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q39505776 | 1985 Kreshover lecture. Molecular factors influencing neutrophil defects in periodontal disease |
| Q47810460 | A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells |
| Q39157245 | A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts |
| Q28239866 | A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage |
| Q45039866 | A multicenter study evaluating the sensitization potential of enamel matrix derivative after treatment of two infrabony defects |
| Q41146678 | A rapid, semi-automated procedure for the evaluation of leukocyte locomotion in the micropore filter assay |
| Q44987499 | A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils |
| Q41973681 | Absence of exogenous interleukin-4-induced apoptosis of gingival macrophages may contribute to chronic inflammation in periodontal diseases |
| Q94593610 | Activation of PPAR-γ induces macrophage polarization and reduces neutrophil migration mediated by heme oxygenase 1 |
| Q36870610 | Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes |
| Q43007771 | Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin |
| Q44040813 | Aggressive periodontitis: 5-year follow-up of treatment |
| Q40146985 | Altered diacylglycerol level and metabolism in neutrophils from patients with localized juvenile periodontitis |
| Q35028677 | Alternative splicing generates a diacylglycerol kinase α transcript that acts as a dominant-negative modulator of superoxide production in localized aggressive periodontitis |
| Q33285989 | An In Vivo Study of Dentin Sensitivity: The Relation of Dentin Sensitivity and the Patency of Dentin Tubules |
| Q90581465 | An appraisal of the role of specific bacteria in the initial pathogenesis of periodontitis |
| Q43223814 | An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. |
| Q39366483 | Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, doubl |
| Q36269340 | Androgen receptors and experimental bone loss - an in vivo and in vitro study. |
| Q31958913 | Animal models for Porphyromonas gingivalis-mediated periodontal disease. |
| Q36283037 | Animal models for periodontal regeneration and peri-implant responses. |
| Q30664773 | Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway |
| Q35633812 | Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression |
| Q28118677 | Assignment of the gene for diacylglycerol kinase (DAGK) to human chromosome 12 |
| Q28115230 | Assignment of the human diacylglycerol kinase gene (DAGK) to 12q13.3 using fluorescence in situ hybridization analysis |
| Q46145392 | Association Between Interleukin‐1 Genotype and Periodontal Disease in a Diabetic Population |
| Q37023067 | Association of an abnormality of neutrophil chemotaxis in human periodontal disease with a cell surface protein |
| Q34071936 | Association of salivary lysozyme and C-reactive protein with metabolic syndrome |
| Q40848557 | Associations Between Sex Hormone Levels and Periodontitis in Men: Results From NHANES III. |
| Q50129587 | Atherosclerosis, Periodontal Disease, and Treatment with Resolvins |
| Q52676365 | Author Correction: ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance. |
| Q37283826 | B cells from periodontal disease patients express surface Toll-like receptor 4 |
| Q33911633 | B cells promote obesity-associated periodontitis and oral pathogen-associated inflammation |
| Q73941076 | Bacterial lipopolysaccharide induces early and late activation of protein kinase C in inflammatory macrophages by selective activation of PKC-epsilon |
| Q41979445 | Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis |
| Q81730085 | Bringing light to the heat: "inflammation and periodontal diseases: a reappraisal" |
| Q45114836 | CD38 cleavage in fMLP- and IL-8-induced chemotaxis is dependent on p38 MAP kinase but independent of p44/42 MAP kinase |
| Q34312899 | CD38 expression in neutrophils from patients with localized aggressive periodontitis |
| Q36007032 | Cardiovascular disease and periodontal diseases: commonality and causation |
| Q81238749 | Cellular and molecular susceptibility determinants for periodontitis |
| Q37415326 | Ceruloplasmin induces polymorphonuclear leukocyte priming in localized aggressive periodontitis |
| Q44204197 | Change of antibiotic susceptibility following periodontal therapy. A pilot study in aggressive periodontal disease |
| Q36948304 | Characterization of GP110, a neutrophil surface protein |
| Q91542906 | Characterization of periodontitis in people with type 1 diabetes of 50 years or longer duration |
| Q40624375 | Chronic Periodontitis Is Associated With Spinal Dysmobility in Patients With Ankylosing Spondylitis |
| Q37415343 | Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. |
| Q43918467 | Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis: a phase-2 multi-center study |
| Q55004886 | Clinical and microbiological parameters of naturally occurring periodontitis in the non-human primate Macaca mulatta. |
| Q34016301 | Clinical and other risk indicators for early periodontitis in adults |
| Q81315078 | Clinical characteristics and microbiota of progressing slight chronic periodontitis in adults |
| Q48101169 | Cloning and characterization of human TNF alpha promoter region |
| Q39641026 | Co-culture of human bone marrow stromal cells with endothelial cells alters gene expression profiles |
| Q39368367 | Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of postoperative pain: a double-blind, placebo- and active-controlled parallel-group study |
| Q87547850 | Commentary: periodontitis is characterized by an immuno-inflammatory host-mediated destruction of bone and connective tissues that support the teeth |
| Q95415919 | Comparison of the impact of scaler material composition on polished titanium implant abutment surfaces |
| Q36768742 | Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray |
| Q82477657 | Compliance as a prognostic indicator: retrospective study of 505 patients treated and maintained for 15 years |
| Q59663784 | Consensus Report: Aggressive Periodontitis |
| Q28221393 | Control of inflammation and periodontitis |
| Q83919206 | Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites |
| Q42923048 | Correction: A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts |
| Q72812995 | Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients |
| Q40571810 | Crown lengthening in mandibular molars: a 5-year retrospective radiographic analysis |
| Q47557607 | Current and Emerging Treatments for Postsurgical Cleft Lip Scarring: Effectiveness and Mechanisms |
| Q52956682 | Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. |
| Q46294827 | De novo bone formation after the sinus lift procedure |
| Q40285024 | Dental plaque microbial profiles of children from Khartoum, Sudan, with congenital heart defects |
| Q92495026 | Development and validation of a predictive model for periodontitis using NHANES 2011-2012 data |
| Q33761398 | Diabetes-induced oxidative stress is mediated by Ca2+-independent phospholipase A2 in neutrophils |
| Q36485310 | Diet-Induced Obesity and Its Differential Impact on Periodontal Bone Loss |
| Q44862526 | Differential effects of growth factors and cytokines on the synthesis of SPARC, DNA, fibronectin and alkaline phosphatase activity in human periodontal ligament cells |
| Q34373321 | Differentiation of HL-60 cells to granulocytes involves regulation of select diacylglycerol kinases (DGKs). |
| Q39512511 | Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB. |
| Q97519129 | Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation |
| Q34019147 | Docosahexaenoic Acid and Periodontitis in Adults: A Randomized Controlled Trial |
| Q35633817 | Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies |
| Q42373874 | ERV1 Overexpression in Myeloid Cells Protects against High Fat Diet Induced Obesity and Glucose Intolerance |
| Q41896374 | Effect of neutrophil apoptosis on monocytic cytokine response to Porphyromonas gingivalis lipopolysaccharide |
| Q51769162 | Effect of the pro-resolution lipid mediator Resolvin E1 (RvE1) on pulp tissues exposed to the oral environment. |
| Q46538933 | Effect of topical cimetidine rinse on gingival crevicular neutrophil leukocyte function |
| Q34306389 | Efficacy of a fluoridated hydrogen peroxide-based mouthrinse for the treatment of gingivitis: a randomized clinical trial |
| Q47231439 | Efficacy of a new papilla generation technique in implant dentistry: a preliminary study. |
| Q43244398 | Efficacy of combined regenerative treatments in human mandibular class II furcation defects |
| Q35853608 | Enamel matrix derivative promotes superoxide production and chemotaxis but reduces matrix metalloproteinase-8 expression by polymorphonuclear leukocytes |
| Q38866495 | Endothelial Cell Response to Fusobacterium nucleatum |
| Q34074823 | Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis |
| Q42596114 | Enhancing the value of scaling and root-planing: Arestin clinical trial results. |
| Q41773703 | Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. |
| Q91921361 | Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes |
| Q46276363 | GABAB Receptors as Modulating Target for Inflammatory Responses of the Periodontal Ligament |
| Q73187007 | Genetic studies of syndromes with severe periodontitis and palmoplantar hyperkeratosis |
| Q33226098 | Gingipain-specific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis |
| Q36319352 | Gingivitis susceptibility and its relation to periodontitis in men |
| Q38375511 | Group A. Consensus paper. Plaque control--home remedies practiced in developing countries |
| Q54484314 | Group A. Reactor Paper. Plaque control: home remedies practiced in developing countries. |
| Q24681331 | Haim-Munk syndrome and Papillon-Lefèvre syndrome are allelic mutations in cathepsin C |
| Q83432613 | Have we become so focused on inflammation and host response that we have neglected the role of bacteria in initiating periodontal disease? |
| Q35499918 | Hemin-induced modifications of the antigenicity and hemin-binding capacity of Porphyromonas gingivalis lipopolysaccharide |
| Q46156591 | Hereditary gingival fibromatosis associated with generalized aggressive periodontitis: a case report |
| Q44804684 | High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. |
| Q40113612 | Host modulation: controlling the inflammation to control the infection |
| Q36362712 | Host-mediated resolution of inflammation in periodontal diseases |
| Q61284306 | Human histone genes are interspersed with members of the Alu family and with other transcribed sequences |
| Q60954623 | Hypoxia-induced endothelial cell responses - possible roles during periodontal disease |
| Q36691364 | IPLA2 mRNA expression by human neutrophils in type 2 diabetes and chronic periodontitis |
| Q100311146 | Identification and Characterization of a Novel Adiponectin Receptor Agonist AdipoAI and its Anti-Inflammatory Effects in vitro and in vivo |
| Q34225421 | Identification of mRNAs for the various diacylglycerol kinase isoforms in neutrophils from patients with localized aggressive periodontitis. |
| Q47807401 | IgG antibody levels to Porphyromonas gingivalis and clinical measures in children |
| Q40208063 | Impact of Docosahexaenoic Acid Therapy on Subgingival Plaque Microbiota |
| Q37677943 | Impact of periodontal therapy on the subgingival microbiota of severe periodontitis: comparison between good responders and individuals with refractory periodontitis using the human oral microbe identification microarray |
| Q34955621 | Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes |
| Q28740401 | Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1 |
| Q28573336 | In vivo up-regulation of kinin B1 receptors after treatment with Porphyromonas gingivalis lipopolysaccharide in rat paw |
| Q61631290 | Inducible nitric oxide synthase mediates bone development and P. gingivalis-induced alveolar bone loss |
| Q38102712 | Infection and inflammatory mechanisms |
| Q44958112 | Infection and inflammatory mechanisms. |
| Q35821931 | Inflammation and Genetic Risk Indicators for Early Periodontitis in Adults |
| Q37232596 | Inflammation and factors that may regulate inflammatory response |
| Q81730146 | Inflammation and periodontal diseases: a reappraisal |
| Q38169798 | Inflammatory and immune pathways in the pathogenesis of periodontal disease |
| Q69772088 | Inhibition of gingivitis by topical application of ebselen and rosmarinic acid |
| Q46285071 | Intracanal delivery of Resolvin E1 controls inflammation in necrotic immature rat teeth |
| Q98210980 | Investigating the Response of Human Neutrophils to Hydrophilic and Hydrophobic Micro-Rough Titanium Surfaces |
| Q70905764 | Juvenile periodontitis as a model for neutrophil function: reduced binding of the complement chemotactic fragment, C5a |
| Q36021645 | LXA4 actions direct fibroblast function and wound closure |
| Q36753685 | Lack of p47(phox) in Akita Diabetic Mice Is Associated with Interstitial Pneumonia, Fibrosis, and Oral Inflammation |
| Q71703879 | Lipopolysaccharide priming of superoxide release by human neutrophils: role of membrane CD14 and serum LPS binding protein |
| Q35404425 | Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor(s) on human tumor necrosis factor alpha promoter |
| Q37084615 | Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo |
| Q60731340 | Lipoxin A4Analogues Inhibit Leukocyte Recruitment toPorphyromonas gingivalis: A Role for Cyclooxygenase-2 and Lipoxins in Periodontal Disease† |
| Q36175657 | Lipoxin signaling in neutrophils and their role in periodontal disease |
| Q28196238 | Lipoxins in chronic inflammation |
| Q35984105 | Local and cardiorenal effects of periodontitis in nitric oxide-deficient hypertensive rats. |
| Q74739843 | Local, regional, and global partnerships in developing a research program |
| Q52096289 | Localized aggressive periodontitis is linked to human chromosome 1q25. |
| Q39848278 | Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions |
| Q34505126 | Maresin 1 Biosynthesis and Proresolving Anti-infective Functions with Human-Localized Aggressive Periodontitis Leukocytes |
| Q100991881 | Maresin-1 and Resolvin E1 Promote Regenerative Properties of Periodontal Ligament Stem Cells Under Inflammatory Conditions |
| Q73187026 | Markers of bone and cementum formation accumulate in tissues regenerated in periodontal defects treated with expanded polytetrafluoroethylene membranes |
| Q46223376 | Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. |
| Q28590692 | Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis |
| Q81930108 | Modeling of trabecular bone and lamina dura following selective alveolar decortication in rats |
| Q39612870 | Moesin functions as a lipopolysaccharide receptor on human monocytes. |
| Q39693467 | Moesin-induced signaling in response to lipopolysaccharide in macrophages |
| Q73187013 | Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation |
| Q38127782 | Natural resolution of inflammation |
| Q40403668 | Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes |
| Q68112358 | Neutrophil defects and host-parasite interactions in the pathogenesis of localized juvenile periodontitis |
| Q70930091 | Neutrophil receptor modulation in the pathogenesis of periodontal diseases |
| Q35096581 | Neutrophil-mediated host response to Porphyromonas gingivalis. |
| Q35068805 | Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis |
| Q36315679 | New agents in the chemical control of plaque and gingivitis--reaction paper |
| Q37602528 | Number of teeth, C-reactive protein, fibrinogen and cardiovascular mortality: a 15-year follow-up study in a Finnish cohort |
| Q91891365 | Omega-3 Fatty Acids Effects on Inflammatory Biomarkers and Lipid Profiles among Diabetic and Cardiovascular Disease Patients: A Systematic Review and Meta-Analysis |
| Q100295916 | Omega-3 Fatty Acids and Low-Dose Aspirin in the Treatment of Periodontitis and Metabolic Syndrome: Case Report |
| Q89903502 | Omega-3 PUFA and aspirin as adjuncts to periodontal debridement in patients with periodontitis and type 2 diabetes mellitus. Randomized clinical trial |
| Q36953341 | Oral infection, hyperglycemia, and endothelial dysfunction |
| Q38429185 | Oral infections and cardiovascular disease |
| Q35963446 | Oral inflammatory diseases and systemic inflammation: role of the macrophage. |
| Q35092082 | Origin and function of the cellular components in gingival crevice fluid |
| Q41856258 | PDK1 regulates chemotaxis in human neutrophils |
| Q77146333 | PMN responses in chronic periodontal disease: evaluation by gingival crevicular fluid enzymes and elastase-alpha-1-proteinase inhibitor complex |
| Q126273813 | PO19-593 SALIVARY IMMUNOGLOBULINS AND RISK OF CORONARY ARTERY DISEASE |
| Q37096266 | Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it |
| Q37964882 | Paradigm shift in the pharmacological management of periodontal diseases |
| Q34663573 | Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women |
| Q92047488 | Periodontal Disease Associates With Arterial Inflammation Via Potentiation of a Hematopoietic-Arterial Axis |
| Q61704060 | Periodontal Disease Is Associated With Brachial Artery Endothelial Dysfunction and Systemic Inflammation |
| Q72774982 | Periodontal diseases and impaired neutrophil function |
| Q56967713 | Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions |
| Q56968039 | Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions |
| Q39427012 | Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases |
| Q86685086 | Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases |
| Q95796135 | Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAPWorkshop on Periodontitis and Systemic Diseases |
| Q36953771 | Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts |
| Q45272768 | Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation. |
| Q36294444 | Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus |
| Q80068935 | Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties |
| Q37546378 | Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model |
| Q39794007 | Porphyromonas gingivalis-induced production of reactive oxygen species, tumor necrosis factor-α, interleukin-6, CXCL8 and CCL2 by neutrophils from localized aggressive periodontitis and healthy donors: modulating actions of red blood cells and resol |
| Q37026086 | Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease |
| Q50881072 | Prevalence of dental caries and treatment needs in the school-going children of rural areas in Udaipur district. |
| Q80694180 | Prevalence of gingival diseases, malocclusion and fluorosis in school-going children of rural areas in Udaipur district |
| Q37415313 | Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase |
| Q38797250 | Pro-resolving mediators in the regulation of periodontal disease |
| Q51281104 | Propolis Improves Periodontal Status and Glycemic Control in Patients With Type 2 Diabetes Mellitus and Chronic Periodontitis: A Randomized Clinical Trial. |
| Q90734155 | Proposal of a Clinical Endpoint for Periodontal Trials: The Treat-to-Target Approach |
| Q37842643 | Proresolving lipid mediators: potential for prevention and treatment of periodontitis. |
| Q34734374 | Proresolving nanomedicines activate bone regeneration in periodontitis. |
| Q74640927 | Rapid evaluation of serum and gingival crevicular fluid immunoglobulin G subclass antibody levels in patients with early-onset periodontitis using checkerboard immunoblotting |
| Q38204891 | Recent advances in host defense mechanisms/therapies against oral infectious diseases and consequences for systemic disease. |
| Q72905165 | Reduced chemotactic peptide binding in juvenile periodontitis: A model for neutrophil function |
| Q34282093 | Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators |
| Q84774661 | Reducing the risk of CVD in patients with periodontitis |
| Q71590008 | Regression line analysis of neutrophil chemotaxis |
| Q72663844 | Regulation of Porphyromonas gingivalis virulence: hemin limitation effects on the outer membrane protein (OMP) expression and biological activity |
| Q87806993 | Reply: is it not timely to consider how to balance cardiorenometabolic benefits and risks of statins? |
| Q88056735 | Research Objectives for the Study of Early-Onset Periodontitis. A Summary of the Working Groups for the Early-Onset Periodontitis Workshop |
| Q77145547 | Resolution of crevicular fluid leukocyte activity in patients treated for aggressive periodontal disease |
| Q36309261 | Resolution of inflammation in periodontitis |
| Q41912989 | Resolution of inflammation-unraveling mechanistic links between periodontitis and cardiovascular disease |
| Q28206660 | Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases |
| Q28539312 | Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury |
| Q37142408 | Resolvin D1 protects periodontal ligament |
| Q64100490 | Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis |
| Q55250059 | Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis. |
| Q35555554 | Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis |
| Q55400671 | Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions. |
| Q39471464 | Resolvin E1 Reverses Experimental Periodontitis and Dysbiosis. |
| Q36514361 | Resolvin E1 and chemokine-like receptor 1 mediate bone preservation |
| Q30493174 | Resolvin E1 receptor activation signals phosphorylation and phagocytosis |
| Q34315513 | Resolvin E1 regulates adenosine diphosphate activation of human platelets |
| Q46915116 | Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. |
| Q37022898 | Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1. |
| Q83281987 | Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease |
| Q81452266 | Risk factors for periodontitis |
| Q91966684 | Robert J. Genco, DDS, PhD: Legacy of a renowned and visionary periodontal researcher who shaped our knowledge of periodontitis and systemic diseases |
| Q39912939 | Role for Periodontitis in the Progression of Lipid Deposition in an Animal Model |
| Q34116056 | Role for fimbriae and lysine-specific cysteine proteinase gingipain K in expression of interleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells. |
| Q40574732 | Role for moesin in lipopolysaccharide-stimulated signal transduction |
| Q26994711 | Role of suppressors of cytokine signaling 3 in bone inflammatory responses |
| Q39825888 | Role of the neutrophil in oral disease: receptor deficiency in leukocytes from patients with juvenile periodontitis. |
| Q39812114 | SOCS-3 Regulates Alveolar Bone Loss in Experimental Periodontitis |
| Q35121896 | Salivary immunoglobulins and prevalent coronary artery disease |
| Q36870604 | Salivary lysozyme and prevalent coronary heart disease: possible effects of oral health on endothelial dysfunction |
| Q33954476 | Salivary lysozyme and prevalent hypertension |
| Q42412271 | Sequential chemotactic and phagocytic activation of human polymorphonuclear neutrophils |
| Q95647563 | Shifting the paradigm from inhibitors of inflammation to resolvers of inflammation in periodontitis |
| Q34016349 | Simultaneous measurements of cytoplasmic Ca2+ responses and intracellular pH in neutrophils of localized aggressive periodontitis (LAP) patients. |
| Q112566671 | Specialized Pro-Resolving Mediators Reduce Scarring After Cleft Lip Repair |
| Q47665529 | Spontaneous PMN apoptosis in type 2 diabetes and the impact of periodontitis. |
| Q38739537 | Strain-Specific Impact of Fusobacterium nucleatum on Neutrophil Function |
| Q33754794 | Strain-dependent activation of monocytes and inflammatory macrophages by lipopolysaccharide of Porphyromonas gingivalis |
| Q80802648 | Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial |
| Q40152958 | Subclass and molecular form of immunoglobulin A antibodies to Actinobacillus actinomycetemcomitans in juvenile periodontitis |
| Q35633807 | Subgingival and tongue microbiota during early periodontitis |
| Q41610191 | Subgingival microbial profiles of Sudanese patients with aggressive periodontitis. |
| Q48672525 | Summary of panel discussion. 1--Is there a conflict between the postgraduate education of the clinician and the academic researcher? |
| Q84032441 | Superficial topography and porosity of an absorbable barrier membrane impacts soft tissue response in guided bone regeneration |
| Q51829140 | Systemic MMP inhibition for periodontal wound repair: results of a multi-centre randomized-controlled clinical trial. |
| Q33775405 | TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients |
| Q72354599 | TNF alpha and IL-1 beta in serum of LJP patients with normal and defective neutrophil chemotaxis |
| Q49584285 | Task Force on Design and Analysis in Oral Health Research: Host-Microbiome Interactions in Dysbiosis. |
| Q35910549 | Testosterone regulates bone response to inflammation. |
| Q34990556 | The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease |
| Q51822430 | The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. |
| Q91973548 | The Nexus Between Periodontal Inflammation and Dysbiosis |
| Q72812165 | The Papillon-Lefèvre syndrome: Neutrophil dysfunction with severe periodontal disease |
| Q51696516 | The Periodontitis and Vascular Events (PAVE) pilot study: adverse events. |
| Q94679713 | The Periodontitis and Vascular Events (PAVE) pilot study: recruitment, retention, and community care controls |
| Q42596122 | The challenge of treating periodontal patients who smoke--the efficacy of Arestin. |
| Q81400567 | The clinical significance of new therapies for the management of periodontal disease |
| Q38231443 | The complement system and its role in the pathogenesis of periodontitis: current concepts. |
| Q67559150 | The effect of titanium implant abutment surface irregularities on plaque accumulation in vivo |
| Q45332487 | The effects of xerogenic medications on oral mucosa among the Veterans Dental Study participants. |
| Q83195856 | The etiology and pathogenesis of periodontitis revisited |
| Q38029704 | The impact of genotypes and immune reactivity on peri-implant inflammation: Identification and therapeutic use of anti-inflammatory drugs and immunomodulators |
| Q37232631 | The management of inflammation in periodontal disease |
| Q35852495 | The multi-center randomized controlled trial (RCT) published by the journal of the American Medical Association (JAMA) on the effect of periodontal therapy on glycated hemoglobin (HbA1c) has fundamental problems |
| Q74287985 | The oral/dental/craniofacial complex as a model for inflammatory disease |
| Q81055335 | The relationship between Porphyromonas gingivalis infection and local and systemic factors in children |
| Q45085288 | The relationship between oral infections and systemic disease. |
| Q94581355 | The role of inflammation and genetics in periodontal disease |
| Q35246409 | The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation |
| Q94581389 | The role of the microbiota in periodontal disease |
| Q41819128 | The use of light/chemically hardened polymethylmethacrylate, polyhydroxyethylmethacrylate, and calcium hydroxide graft material in combination with polyanhydride around implants in minipigs: part I: immediate stability and function |
| Q42618485 | The use of light/chemically hardened polymethylmethacrylate, polyhydroxylethylmethacrylate, and calcium hydroxide graft material in combination with polyanhydride around implants and extraction sockets in minipigs: Part II: histologic and micro-CT e |
| Q37058550 | The use of rodent models to investigate host-bacteria interactions related to periodontal diseases |
| Q36863273 | Therapeutic Targets for Management of Periodontitis and Diabetes |
| Q47121974 | Therapeutic Targets for Management of Periodontitis and Diabetes |
| Q74533069 | Thwarting host immune responses in periodontal disease |
| Q33954398 | Toll-like receptors regulate B cell cytokine production in patients with diabetes |
| Q42078230 | Topical H2 antagonist prevents periodontitis in a rabbit model |
| Q81521857 | Treatment of intrabony defects using guided tissue regeneration and autogenous spongiosa alone or combined with hydroxyapatite/beta-tricalcium phosphate bone substitute or bovine-derived xenograft |
| Q36408163 | Type 1 diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation in vivo |
| Q92077055 | Understanding resolution of inflammation in periodontal diseases: Is chronic inflammatory periodontitis a failure to resolve? |
| Q42749443 | Unraveling the link between periodontitis and cardiovascular disease |
| Q35920304 | Verification of γ-Amino-Butyric Acid (GABA) Signaling System Components in Periodontal Ligament Cells In Vivo and In Vitro |
| Q57218053 | [Attenuation of experimental peritonitis and periodontitis in human chemokine-like receptor 1 (CMKLR1 or hChemR23) transgenic mice] |
| Q83838682 | [The pathogenesis of periodontal disease: a paradigm shift] |
| Q35991875 | iNOS-derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats |
| Q44590788 | p21-Activated Kinase 2 in Neutrophils Can Be Regulated by Phosphorylation at Multiple Sites and by a Variety of Protein Phosphatases |
Search more.